Senior insider sale
SUPERNUS PHARMACEUTICALS, INC. — senior position signals high conviction
$387.8K
10.70K shares
What this filing means
NEWHALL CHARLES W III plans to sell 10.70K shares of SUPERNUS PHARMACEUTICALS, INC. valued at approximately $387.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/12/2024ACC: 0001950047-24-008417
Director
Since Feb 2026
10.70K
Shares to sell
$387.8K
Approx. market value
10.70K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of options under a registered plan
Cash
11/11/2024
10.70KTotal acquired10.70K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/11/2024 | Exercise of options under a registered plan Cash | 10.70K | — |
| Total | 10.70K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
10.70K
Market value
$387.8K
11/11/2024
Total
Units
10.70K
Value
$387.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
11/11/2024 | 10.70K | $387.8K | NASDAQ | Planned |
| Total | 10.70K | $387.8K | ||